Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
"Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant". Transplant international : official journal of the European Society for Organ Transplantation Avolio, A. W., Contegiacomo, A., Spoletini, G., Moschetta, G., Bianco, G., Agnes, S., Melcher, M. L., Burra, P. 2021
Abstract
We read with interest the study of Van den Eynde et al. on the effect of perfusion solutions on liver transplant outcome.(1) Graft dysfunction was analyzed applying two indicators: Early Allograft Dysfunction (EAD, a dichotomous system based on transaminase, bilirubin, and coagulation cut-off values)(2) and Model of Early Allograft Function (MEAF, a continuous score based on the same variables as EAD).( 3).
View details for DOI 10.1111/tri.14162
View details for PubMedID 34784075